Selective androgen receptor degrader (sard) ligands and methods of use thereof
US-2018273487-A1 · Sep 27, 2018 · US
Estrogen receptor modulators
US10959989B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10959989-B2 |
| Application number | US-202016866995-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 5, 2020 |
| Priority date | Apr 1, 2016 |
| Publication date | Mar 30, 2021 |
| Grant date | Mar 30, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound selected from the group consisting of 2. A compound of the following Formula 11-4: 3. A compound of the following Formula 11-5:
Assignees
Inventors
Classifications
- C07D471/04Primary
Ortho-condensed systems · CPC title
- A61K31/438Primary
The ring being spiro-condensed with carbocyclic or heterocyclic ring systems · CPC title
Radicals substituted by nitrogen atoms, not forming part of a nitro radical · CPC title
having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] in the acid moiety · CPC title
Esters of keto-carboxylic acids {or aldehydo-carboxylic acids} · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10959989B2 cover?
- Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessiv…
- Who is the assignee on this patent?
- Recurium Ip Holdings Llc
- What technology area does this patent fall under?
- Primary CPC classification C07D471/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).